Elisha Y. Goldberg
Nessuna posizione attualmente
Profilo
Elisha Y.
Goldberg is former Director-Business Development at Angion Biomedica Corp.
Precedenti posizioni note di Elisha Y. Goldberg
Società | Posizione | Fine |
---|---|---|
ANGN BIOM | Corporate Officer/Principal | 31/01/2022 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
Angion Biomedica Corp.
Angion Biomedica Corp. Pharmaceuticals: MajorHealth Technology Angion Biomedica Corp. operates as a biopharmaceutical company. The firm focuses on the discovery and development of novel therapeutic agents to address acute organ injuries and fibrotic diseases. Its product pipeline includes ANG-3777, ANG-3070, ROCK2 Inhibitor and CYP11B2 Inhibitors. The company was founded by Itzhak D. Goldberg on April 6, 1998 and is headquartered in Newton, MA. | Health Technology |